48,830
edits
Difference between revisions of "Adenosquamous carcinoma of the lung"
Jump to navigation
Jump to search
Adenosquamous carcinoma of the lung (view source)
Revision as of 01:44, 9 April 2014
, 01:44, 9 April 2014no edit summary
| Line 4: | Line 4: | ||
==General== | ==General== | ||
*Respond to [[ | *Rare. | ||
*Respond to [[tyrosine kinase inhibitors]].<ref name=pmid23769878>{{Cite journal | last1 = Song | first1 = Z. | last2 = Lin | first2 = B. | last3 = Shao | first3 = L. | last4 = Zhang | first4 = Y. | title = Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma. | journal = J Chin Med Assoc | volume = 76 | issue = 9 | pages = 481-5 | month = Sep | year = 2013 | doi = 10.1016/j.jcma.2013.05.007 | PMID = 23769878 }}</ref><ref namd=pmid23037472>{{Cite journal | last1 = Iwanaga | first1 = K. | last2 = Sueoka-Aragane | first2 = N. | last3 = Nakamura | first3 = T. | last4 = Mori | first4 = D. | last5 = Kimura | first5 = S. | title = The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib. | journal = Intern Med | volume = 51 | issue = 19 | pages = 2771-4 | month = | year = 2012 | doi = | PMID = 23037472 }}</ref> | |||
==Microscopic== | ==Microscopic== | ||
| Line 17: | Line 18: | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||
[[Category:Lung tumours]] | [[Category:Lung tumours]] | ||